These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 26829745)
1. [Progress in research on defective protein trafficking and functional restoration in HERG-associated long QT syndrome]. Fang P; Lian J Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Feb; 33(1):101-4. PubMed ID: 26829745 [TBL] [Abstract][Full Text] [Related]
2. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism. Anderson CL; Delisle BP; Anson BD; Kilby JA; Will ML; Tester DJ; Gong Q; Zhou Z; Ackerman MJ; January CT Circulation; 2006 Jan; 113(3):365-73. PubMed ID: 16432067 [TBL] [Abstract][Full Text] [Related]
3. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications. Thomas D; Karle CA; Kiehn J Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254 [TBL] [Abstract][Full Text] [Related]
4. Novel characteristics of a trafficking-defective G572R-hERG channel linked to hereditary long QT syndrome. Lian J; Huang N; Zhou J; Ge S; Huang X; Huo J; Liu L; Xu W; Zhang S; Yang X; Zhou J; Huang C Can J Cardiol; 2010 Oct; 26(8):417-22. PubMed ID: 20931094 [TBL] [Abstract][Full Text] [Related]
5. Defective protein trafficking in hERG-associated hereditary long QT syndrome (LQT2): molecular mechanisms and restoration of intracellular protein processing. Thomas D; Kiehn J; Katus HA; Karle CA Cardiovasc Res; 2003 Nov; 60(2):235-41. PubMed ID: 14613852 [TBL] [Abstract][Full Text] [Related]
6. hERG channel trafficking: novel targets in drug-induced long QT syndrome. Dennis A; Wang L; Wan X; Ficker E Biochem Soc Trans; 2007 Nov; 35(Pt 5):1060-3. PubMed ID: 17956279 [TBL] [Abstract][Full Text] [Related]
7. hERG: protein trafficking and potential for therapy and drug side effects. Staudacher I; Schweizer PA; Katus HA; Thomas D Curr Opin Drug Discov Devel; 2010 Jan; 13(1):23-30. PubMed ID: 20047143 [TBL] [Abstract][Full Text] [Related]
8. Human ether-a-go-go related gene (hERG) K+ channels: function and dysfunction. Perrin MJ; Subbiah RN; Vandenberg JI; Hill AP Prog Biophys Mol Biol; 2008; 98(2-3):137-48. PubMed ID: 19027781 [TBL] [Abstract][Full Text] [Related]
9. [HERG K+ channel, the target of anti-arrhythmias drugs]. Guan FY; Yang SJ Yao Xue Xue Bao; 2007 Jul; 42(7):687-91. PubMed ID: 17882949 [TBL] [Abstract][Full Text] [Related]
10. LQT2 nonsense mutations generate trafficking defective NH2-terminally truncated channels by the reinitiation of translation. Stump MR; Gong Q; Zhou Z Am J Physiol Heart Circ Physiol; 2013 Nov; 305(9):H1397-404. PubMed ID: 23997099 [TBL] [Abstract][Full Text] [Related]
11. Mouse ERG K(+) channel clones reveal differences in protein trafficking and function. Lin EC; Moungey BM; Lim E; Concannon SP; Anderson CL; Kyle JW; Makielski JC; Balijepalli SY; January CT J Am Heart Assoc; 2014 Dec; 3(6):e001491. PubMed ID: 25497881 [TBL] [Abstract][Full Text] [Related]
12. Identification and functional characterization of the human ether-a-go-go-related gene Q738X mutant associated with hereditary long QT syndrome type 2. Han SN; Yang SH; Zhang Y; Sun XY; Duan YY; Hu XJ; Fan TL; Huang CZ; Yang G; Zhang Z; Zhang L Int J Mol Med; 2014 Sep; 34(3):810-5. PubMed ID: 24993425 [TBL] [Abstract][Full Text] [Related]
13. Probucol aggravates long QT syndrome associated with a novel missense mutation M124T in the N-terminus of HERG. Hayashi K; Shimizu M; Ino H; Yamaguchi M; Terai H; Hoshi N; Higashida H; Terashima N; Uno Y; Kanaya H; Mabuchi H Clin Sci (Lond); 2004 Aug; 107(2):175-82. PubMed ID: 15043509 [TBL] [Abstract][Full Text] [Related]
14. Identification and functional characterization of the novel human ether-a-go-go-related gene (hERG) R744P mutant associated with hereditary long QT syndrome 2. Aidery P; Kisselbach J; Gaspar H; Baldea I; Schweizer PA; Becker R; Katus HA; Thomas D Biochem Biophys Res Commun; 2012 Feb; 418(4):830-5. PubMed ID: 22314138 [TBL] [Abstract][Full Text] [Related]
15. HERG trafficking and pharmacological rescue of LQTS-2 mutant channels. Robertson GA; January CT Handb Exp Pharmacol; 2006; (171):349-55. PubMed ID: 16610352 [TBL] [Abstract][Full Text] [Related]
16. Defective assembly and trafficking of mutant HERG channels with C-terminal truncations in long QT syndrome. Gong Q; Keeney DR; Robinson JC; Zhou Z J Mol Cell Cardiol; 2004 Dec; 37(6):1225-33. PubMed ID: 15572053 [TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms for drug interactions with hERG that cause long QT syndrome. Stansfeld PJ; Sutcliffe MJ; Mitcheson JS Expert Opin Drug Metab Toxicol; 2006 Feb; 2(1):81-94. PubMed ID: 16863470 [TBL] [Abstract][Full Text] [Related]
19. Acquired QT interval prolongation and HERG: implications for drug discovery and development. Finlayson K; Witchel HJ; McCulloch J; Sharkey J Eur J Pharmacol; 2004 Oct; 500(1-3):129-42. PubMed ID: 15464027 [TBL] [Abstract][Full Text] [Related]
20. Rescue of aberrant gating by a genetically encoded PAS (Per-Arnt-Sim) domain in several long QT syndrome mutant human ether-á-go-go-related gene potassium channels. Gianulis EC; Trudeau MC J Biol Chem; 2011 Jun; 286(25):22160-9. PubMed ID: 21536673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]